Investing.com - Financial Markets Worldwide

Aoxing Pharmaceutical Company Inc (AOXG)

OTC Markets
Currency in USD
0.0066
0.0000(0.00%)
Closed·
AOXG Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
AOXG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.00660.0066
52 wk Range
0.00460.0178
Key Statistics
Edit
Prev. Close
0.0066
Open
0.0066
Day's Range
0.0066-0.0066
52 wk Range
0.0046-0.0178
Volume
1.5K
Average Volume (3m)
89.49K
1-Year Change
6.45%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AOXG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 6
Stock generally trades with high price volatility
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Aoxing Pharmaceutical Company Inc Company Profile

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China. The company’s principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.

Industry
Professional & Business Education
Sector
Academic & Educational Services
Employees
346
Market
United States

Compare AOXG to Peers and Sector

Metrics to compare
AOXG
Peers
Sector
Relationship
P/E Ratio
0.0x−0.1x−0.6x
PEG Ratio
0.000.010.00
Price/Book
0.0x0.9x2.6x
Price / LTM Sales
0.0x1.6x3.3x
Upside (Analyst Target)
0.0%189.8%40.2%
Fair Value Upside
Unlock−5.8%5.1%Unlock

Earnings

Latest Release
Feb 10, 2025
EPS / Forecast
-- / --
Revenue / Forecast
5.70M / --
EPS Revisions
a
a
Unlock
Last 90 days

AOXG Income Statement

FAQ

What Stock Exchange Does Aoxing Pharma Trade On?

Aoxing Pharma is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Aoxing Pharma?

The stock symbol for Aoxing Pharma is "AOXG."

What Is the Aoxing Pharma Market Cap?

As of today, Aoxing Pharma market cap is 2.52M.

What Is Aoxing Pharma's Earnings Per Share (TTM)?

The Aoxing Pharma EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is AOXG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Aoxing Pharma Stock Split?

Aoxing Pharma has split 3 times.

How Many Employees Does Aoxing Pharma Have?

Aoxing Pharma has 346 employees.

What is the current trading status of Aoxing Pharma (AOXG)?

As of 17 Aug 2025, Aoxing Pharma (AOXG) is trading at a price of 0.01, with a previous close of 0.01. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.00 to 0.02.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.